Interventional device developer C. R. Bard's board of directors has authorized the repurchase of up to $500 million of the company's common stock.
This is in addition to approximately $30 million remaining under the prior authorization announced in January 2014, according to the firm.
The company's board also increased the quarterly dividend on Bard's common stock by 5%. The dividend is payable on August 1 to shareholders of record at the close of business on July 21.
